Merck Provides Update on REVEAL Outcomes Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. LITE
4. PLTR
5. REGN
6. MRVL
7. ABBV
8. CL
9. CHKP
10. TFII

Go back to Merck Provides Update on REVEAL Outcomes Study

Merck (MRK) Announces DMC Recommendation that REVEAL Study Continue Without Changes

November 13, 2015 8:01 AM EST

Merck (NYSE: MRK) announced that the Data Monitoring Committee (DMC) of the REVEAL outcomes study for anacetrapib has completed its planned review of unblinded study data and recommended the study continue with no changes. The DMC reviewed safety and efficacy data from the study,... More